A novel killer toxin, labelled as KT4561, secreted by Williopsis saturnus DBVPG 4561, was found to possess a wide antimycotic activity against strains of Candida glabrata, Issatchenkia orientalis and Pichia Pichia guillermondii. KT4561 was precipitated by ethanol and purified by ion-exchange chromatography. The active protein migrated as a single band in SDS-PAGE and was characterized by a molecular weight of 62 kDa. Purified KT4561 was active across wide ranges of temperature (5-45°C) and pH (4.5-8.0) and displayed a rapid decrease in viability of yeast cells after 4-8 h. The in vitro activity of KT4561 against 102 yeast isolates (79% of clinical origin) was determined: MIC 50 and MIC 90 of strains were 0.08 and 0.15 lg/ml for C. glabrata, 0.03 and 0.23 lg/ml for I. orientalis and 1.50 and 2.25 lg/ml for P. guilliermondii. Comparative susceptibility tests showed that a high number of strains used in the present study were insensitive to selected azole and polyene antibiotics. The present study demonstrated the potential of KT4561 to be applied as novel control agent against pathogenic yeasts.
Introduction
After the early discovery of the killer phenomenon in strains of Saccharomyces cerevisiae in the 1960s [1] , killer activity has been observed in more than 90 yeast species [2] and several killer proteins (mycocins) produced by strains belonging to species of the genera Debaryomyces, Hanseniaspora, Kluyveromyces, Pichia, Saccharomyces, Schwanniomyces and Williopsis have been extensively studied [2] [3] [4] [5] [6] [7] .
A few potential uses of the killer phenomenon have also been proposed: (i) biocontrol against spoilage yeasts and moulds in fermentation processes or in treatment of post-harvest in fruits and cereals [2, 4, [8] [9] [10] [11] ; (ii) fingerprinting of yeast cultures of clinical or industrial interest [12] [13] [14] [15] [16] [17] and (iii) biomedical applications as novel antimycotic agents [4, 7, [18] [19] [20] [21] [22] .
Although topical applications on superficial skin lesions have been proposed [4, 20, 21] , the use of purified killer toxins for topical treatments against pathogenic yeasts is presently limited because the killer proteins so far studied do not conserve their activity at 37°C and over pH 5.5 [2, 4, 19, 22, 23] .
A previous study [24] indicated that the killer protein produced by Williopsis saturnus DBVPG 4561 was characterized by a broad activity towards strains belonging to some Candida non-albicans species. Among them, Candida glabrata, Issatchenkia orientalis (currently described in clinical practice by means of its anamorphic state Candida krusei) and Pichia guilliermondii (Candida guilliermondii) have in recent years gained the status of emerging yeast pathogens because they are often implicated in causing opportunistic infection [25, 26] .
In this study we describe the characterization of the in vitro antimycotic activity possessed by a novel mycocin (labelled as KT4561) secreted by a strain of W. saturnus (Klö cker) Zender against pathogenic yeasts belonging to the species C. glabrata, I. orientalis and P. guilliermondii.
Materials and methods

Chemicals
DEAE-Biogel A and gel electrophoresis reagents were from Bio-Rad (Life Science Research Group, Hercules, CA, USA). Markers for molecular weights of proteins, amphotericin B, clotrimazole, ketoconazole and other products were from Sigma (Sigma-Aldrich, St. Louis, MO, USA).
Yeast strains and media
Williopsis saturnus DBVPG 4561, previously selected as a result of a series of screening surveys for the presence of killer toxins in yeasts isolated from tropical habitats [24] , was used as protein-producing strain. Yeasts used as sensitive strains were as follows (percentages in parenthesis indicate those isolated from clinical specimens): 36 strains of C. glabrata (80%), 40 of I. orientalis (teleomorphic state of C. krusei) (77%) and 26 of P. guilliermondii (teleomorphic state of C. guilliermondii) (81%). All yeast cultures were deposited in the Industrial Yeast Collection DBVPG (http://www.agr.unipg.it/ dbvpg). Working cultures were stored on YEPG (g/l: yeast extract 10, peptone 10, glucose 20) agar slants at 4°C. Killer medium -KM (g/l: yeast extract 10, peptone 20, glucose 20, methylene blue 0.03, buffered, when not otherwise specified, at pH 4.5 with 10 mM citrate-phosphate buffer) was used to assess the killer activity of the toxin [24] .
Preparation of crude killer toxin
Cells of W. saturnus DBVPG 4561, grown for 24 h at 25°C on YEPG agar slants and suspended in sterile distilled water (2 · 10 6 cells/ml), were inoculated in 250 ml of liquid KM to a cell concentration of 1 · 10 5 cells/ml. After growth for 24 h at 25°C in an orbital shaker (140 rpm), pre-cultures were used to inoculate (as above) 2 l of liquid KM. After growth for 24 h at 25°C, the culture broth was separated from cells by centrifugation at 10,000g, for 15 min (5°C).
Killer activity assay
Killer activity was tested by using the agar diffusion well bioassay (ADWB) method [9] . Cells of sensitive yeasts grown for 24 h at 25°C on YEPG agar slants were suspended in sterile distilled water to obtain about 10 5 cells/ml. One milliliter of suspension was mixed with 19 ml of molten KM agar and poured into a Petri dish (100 · 15 mm). Dishes were checked every 12 h for 24-48 h. The appearance of a clear inhibition zone around the killer strain colony surrounded by a crown of dark blue stained cells was recorded as presence of killer activity. Halo areas were measured in digitalized images as previously described [12] . All data on killer activity represented the average value of three separate replicates.
Purification of KT4561: ethanol precipitation
Microcentrifuge filters (Ultrafree-CL, Sigma-Aldrich) with different molecular weight cut-offs (ranges 10, 30 and 100 kDa) were used for a preliminary evaluation of the molecular size of KT4561. Ice-cold ethanol was added to the culture broth to obtain a final percentage of alcohol of 70%. After 12 h at 4°C, the resulting precipitate was collected by centrifugation (10,000g for 30 min) and resuspended in a reduced volume (50 ml) of 10 mM citrate-phosphate buffer (pH 4.5). Ice-cold ethanol was for a second time added to obtain a final percentage of alcohol of 50%: precipitate was discharged and the supernatant (containing the active fraction) was brought with ice-cold ethanol to a final percentage of alcohol of 70%. The resulting precipitate was resuspended in 5 ml of 10 mM sodium citrate-phosphate buffer (pH 4.5). One hundred microliters of concentrated crude killer toxin preparation (10 lg protein/ml) was mixed with 100 lg of both pronase (100 lg/ml) and proteinase K (100 lg/ml) (Sigma). After an incubation period of 18 h at 25°C, the effect of the proteolytic enzymes was evaluated by the above ADWB method.
Purification of KT4561: ion-exchange chromatography
The protein fraction obtained in the previous step (1.73 mg of protein, 5 ml) was applied to a DEAE-Biogel A (Sigma) column (1 · 10 cm) pre-equilibrated with 10 mM Tris-HCl (pH 7.5). Elution was performed by using firstly the 10 mM Tris-HCl (pH 7.5), followed by two steps of 10 mM Tris-HCl (pH 7.5) containing 0.1 and 0.5 M NaCl, respectively. Eluted material was extensively dialyzed vs Tris-HCl 10 mM (pH 7.5) and solutions were concentrated utilizing collodion-bags and an apparatus for concentration (Sartorius AG, Goettingen, Germany). When necessary, further concentration was performed with Microcentrifuge filters Ultrafree-CL (cutoff 10 kDa) (Sigma-Aldrich). The eluted fractions were analyzed for killer toxin activity by the above ADWB method. In this phase, the killer effect of each fraction was quantified in arbitrary units (aU), currently defined as the concentration of purified toxin that caused the inhibition area of 10 mm 2 [27] . The active fraction recovered in the void volume of the column was used for further experiments.
Purification of KT4561: SDS-PAGE
The electrophoretic analysis was carried out as described by Laemmli [28] . The gel, containing 10% acrylamide, was run using the Bio-Rad Mini Protean apparatus and was stained with silver nitrate [29] . The molecular mass of the purified protein was calculated by comparison with known protein markers.
Chemical analyses
Protein concentration of active fractions was determined by the Coomassie blue method [30] . In order to detect the presence of glycoprotein in SDS-PAGE bands the peroxidase assay was employed. The electrophoretically separated protein was transferred to a nitrocellulose membrane and blocked by incubating for 45 min with a 10% solution of foetal calf serum in TBS (50 mM Tris-HCl, 200 mM NaCl, pH 7.4). The blot was then incubated for 3 h in a 10% solution of foetal calf serum in TBS containing Con A-peroxidase (0.5 lg/ml). After washing three times with TBS, the blot was stained for peroxidase activity with 4-chloro-1-naphthol as substrate.
Effect of pH, temperature and salt concentration on KT4561 activity
Purified KT4561 aliquots (10 ll) were used in ADWB analyses on Petri dishes containing KM agar medium buffered at different pH levels (range 4.5-7.5) and the sensitive strain. Plates were incubated at 25°C for 48 h. In addition, purified KT4561 aliquots (10 ll) were used in ADWB analyses on Petri dishes containing KM agar medium buffered at pH 4.5 and the sensitive strain and incubated at different temperatures (range 5-45°C) or with increasing NaCl concentrations (range 6.2-50.0 g/l). In order to assess if KT4561 lost its activity after heat shock, an aliquot of purified protein was kept to 100°C for 10 min: the presence of residual activity was tested by ADWB analyses.
Assessment of fungicidal effect of KT4561
Cells of C. glabrata DBVPG 7212 grown for 24 h at 25°C on YEPG agar slants and suspended in sterile distilled water (2 · 10 7 cells/ml) were inoculated 450 ll of liquid KM to a cell concentration of 1 · 10 6 cells/ml. Aliquots of purified KT4561 were added to obtain concentrations from 0.006 to 3.15 lg/ml. Over a period of 28 h at 37°C, samples were collected at 4-h intervals and viable cells were plated on YEPG agar dishes. Colonies were counted after 48-72 h. A control test (without toxin) was also included.
Antifungal susceptibility tests
Antifungal susceptibility tests of KT4561, amphotericin B, clotrimazole and ketoconazole were performed by a broth microdilution method in agreement with the NCCLS recommendations [31] . The incubation was at 37°C. MIC 50 and MIC 90 were determined for C. glabrata, I. orientalis and P. guilliermondii strains.
Results and discussion
Even though the above reported limitations [2, 4, 19, 22, 23] , the potential exploitation of selected killer proteins as a novel class of antimycotic agents against yeasts of biomedical interest represents, undoubtedly, a particularly fascinating possibility. Therefore, the use of purified killer toxins for direct topic applications against skin mycoses has been suggested [20, 21] .
The killer activity of crude concentrate supernatants of cultures of W. saturnus was completely destroyed after 18 h exposure to proteolytic enzymes. Preliminary data obtained by the use of cut-off filters suggested a molecular weight comprised between 30 and 100 kDa.
Residual killer activities after the main purification steps are reported in Table 1 . After 70% ethanol precipitation, the protein concentration was 1.2% of that measured in the culture broth while the specific killer activity increased about 1700-fold (Table 1) .
KT4561 was eluted as a single peak (V 0 ) after elution of the DEAE-Biogel column with 10 mM Tris-HCl (pH 7.5), while a successive application of a NaCl gradient eluted additional peaks. The V 0 fraction exhibited, after dialysis and concentration, only a single protein band in SDS-PAGE ( Fig. 1(a) ). Aliquots of V 0 fraction tested by ADWB method produced a clear inhibition zone surrounded by a crown of blue-stained cells (Fig. 1(b) ), whereas additional peaks eluted from the column by NaCl gradient exhibited no activity. The molecular weight of the single protein band of V 0 fraction was estimated to be 62 kDa (Fig. 2) . After ion-exchange purification, the protein concentration was 0.02% of that measured in the culture broth while the specific activity of killer toxin increased about 120,000-fold ( Table 1) . The active protein band of fraction V 0 did not stain with 4-chloro-1-naphthol after incubation with Con A-peroxidase, indicating that KT4561 is not a glycoprotein.
Purified KT4561 was found to be active within the a wide range of temperature (5-45°C), pH (4.5-8.0) and NaCl concentrations (6.2-50 g/l) (Fig. 3) . Furthermore, the toxin activity did not significantly (P < 0.01) decrease after heat shock of 100°C for 10 min.
After 28 h exposure at 0.3 lg/ml of KT4561, a considerable reduction (about three logarithmic cycles) of viable cells of C. glabrata DBVPG 7212 was observed (Fig.  4) . This result is in agreement with the existing literature [2] [3] [4] [5] [6] [7] [8] reporting the fungicidal effect of killer toxins. Table 2 summarize the in vitro susceptibilities of 102 yeast strains (79% isolated from clinical specimens). The MIC 50 and MIC 90 of KT4561 were 0.08 and 0.15 lg/ml for C. glabrata, 0.03 and 0.23 lg/ml for I. orientalis and 1.50 and 2.25 g/ml for P. guilliermondii, respectively. On Table 1 Residual killer activity of KT4561 after the main purification steps Purification procedures are described in Section 2. 1 aU (arbitrary unit) = the amount of killer protein that causes an inhibition area of 10 mm the whole, the MICs at which KT4561 inhibited 50% and 90% of total strains were 0.08 and 1.50 lg/ml (Table 2) . By contrast, a considerably high number of I. orientalis strains were insensitive to concentration >100 lg/ml of amphotericin B, whereas a relatively high number of C. glabrata strains were insensitive to concentration >100 lg/ml of azoles (Table 2) . No significant differences were observed in KT4561 susceptibility between strains of clinical or non-clinical origin. Likewise to a previous study describing the properties of a killer protein secreted by Williopsis mrakii [19] , the activity of KT4561 could be affected predominantly by the cell wall characteristics of sensitive strains and, only in a lesser extent, by the micro-environmental condition of the niche of isolation. The broad activity of KT4561, expressed at physiological human body pH and temperature, appears to be promising in relation to its possible applications as a novel antimycotic agent. Although previous screenings [18, 24] indicated that KT4561 did not affect growth of Candida albicans strains, this study showed that this killer protein possessed a broad antimycotic activity against some pathogenic Candida non-albicans species and, more importantly, towards strains insensitive to selected azole and polyene antibiotics. This aspect appears to be of fundamental importance because, in agreement with existing literature [32] [33] [34] , the drug insensitivity is a real problem in clinical set.
Some strains belonging to the genus Williopsis are known to secret mycocins exhibiting anti-Candida activity [2, 4, 5, 19, 22, 35] . Yet, KT4561 is active across a wider range of temperature and pH. Its unusual stability even after heat shock (100°C for 10 min) is apparently 1 Number of strains insensitive at the maximum tested concentrations: KT4561 = 10 lg/ml; KETO = 100 lg/ml; CLO = 100 lg/ml; AMPH B = 100 lg/ml. similar to that previously observed in a few killer toxins produced by Hansenula mrakii (synonym of W. mrakii) and by Cryptococcus humicola [22, 36] . It has been suggested [27] that the presence of heat-stable disulfide bounds in protein molecules rich in cysteine could be responsible for this behavior.
The exact mechanism by which KT4561 exerts its killer action towards pathogenic yeasts remains still unclear. Some previous studies on killer proteins secreted by Williopsis spp. strains [2, 4, 19] could suggest the production of ion channels in the sensitive cells promoting the loss of ions and, ultimately, leading to cell death.
